The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 05, 2017

Filed:

Jun. 14, 2013
Applicant:

Scripps Korea Antibody Institute, Gangwon-do, KR;

Inventors:

Suk Mook Lee, Seoul, KR;

Min kyoung Ki, Seoul, KR;

Mee Hyun Jeoung, Gangwon-do, KR;

Jong Rip Choi, Gangwon-do, KR;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/46 (2006.01); C07K 16/18 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); A61K 47/48 (2006.01); C07K 7/08 (2006.01); C07K 14/435 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 47/48538 (2013.01); C07K 7/08 (2013.01); C07K 14/435 (2013.01); C07K 14/7056 (2013.01); C07K 16/2851 (2013.01); G01N 33/53 (2013.01); C07K 2317/21 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2319/30 (2013.01);
Abstract

Provided is an antibody specifically binding to the CTLD (C-type lectin like domain) of clec14a (C-type lectin domain family 14, member A), a method for preparing the antibody, a composition for suppressing angiogenesis comprising the antibody, a method for suppressing angiogenesis by administering the antibody or the composition, a composition for preventing or treating cancer comprising the antibody, a method for treating cancer by administering the antibody or the composition, a composition for diagnosing cancer comprising the antibody, a kit for diagnosing cancer comprising the composition, a method for diagnosing cancer using the composition, a composition for suppressing angiogenesis comprising a material for inhibiting expression of clec14a, a kit for angiogenesis comprising the composition, a method for suppressing angiogenesis or treating cancer using the composition, and the use of the CTLD of clec14a as an epitope for an antibody suppressive of angiogenesis.


Find Patent Forward Citations

Loading…